Failure to Ensure Availability and Timely Administration of Ordered Pain Interventions
Summary
The deficiency involves the facility’s failure to provide safe, appropriate pain management for a resident with severe, ongoing pain, as required by its pain management policy and licensure regulations. The facility’s policy required systematic recognition, assessment, treatment, and monitoring of pain, including evaluation upon admission, at scheduled intervals, and with changes in condition, and directed staff to notify the practitioner if pain was not controlled. The resident involved had diabetes mellitus type 2, severe cognitive impairment (BIMS score of 6), required extensive to total assistance with most ADLs, and was assessed on the MDS as having pain almost constantly, with pain frequently affecting sleep and almost constantly interfering with therapy. The comprehensive care plan identified potential pain related to diabetic neuropathy in both feet and lower back pain, with goals for adequate pain relief and interventions including the resident’s ability to request help and medication, a preference for medication-based pain control, and use of non-pharmacological measures such as redirection, distraction, and repositioning. The resident’s physician orders included multiple pain interventions: topical Aspercreme with 4% lidocaine to the feet twice daily for neuropathic pain, diclofenac gel to each knee three times daily, a 4% lidocaine patch to the right thigh and back daily for 12 hours on and 12 hours off, pregabalin 150 mg twice daily, and acetaminophen 500 mg every 6 hours as needed for pain. Review of the Treatment Administration Record for April showed that the Aspercreme with lidocaine was not available and was not administered, and that the PRN acetaminophen had not been given at all that month. Progress notes documented repeated entries over several days that the Aspercreme with lidocaine was on order or awaiting delivery from the pharmacy, confirming it remained unavailable for use. Thus, a prescribed topical pain medication specifically ordered for neuropathic foot pain was not accessible or provided to the resident over multiple days. Surveyor observations and interviews further showed failures in timely administration and monitoring of other pain interventions. During a medication pass, an LPN asked the resident to rate their pain; the resident reported a pain level of 10 with throbbing pain. The LPN applied diclofenac cream to the knees, but there was no lidocaine patch on the right leg, and the resident reported that the lidocaine patches due that morning to the right thigh and back had not been applied. Later confirmation from staff showed the lidocaine patches were not applied until midday, and staff acknowledged that, despite the late application, the patch would still be removed at the originally scheduled time, resulting in the resident not receiving the full ordered 12-hour dose. The LPN also confirmed that, despite the resident’s pain level of 10, no non-pharmacological interventions were offered, no PRN acetaminophen was administered, no re-evaluation of the resident’s pain was performed, and the practitioner was not contacted. On a subsequent observation, the resident reported that while knee pain had improved to a 3 with diclofenac, foot pain remained at 10, and the resident stated they had not received the Aspercreme with lidocaine to the feet, which staff confirmed had not been given that week due to unavailability.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.